Search

Author/Creator Oosterwijk, J.

1. FaMRIsc trial shows: MRI breast screening for women with ≥20% lifetime risk is also cost-effective in Europe. Issue 2 (February 2021)

Authors:
Tilanus-Linthorst, Madeleine; Geuzinge, A.; Obdeijn, I.M.; Rutgers, E.; Mann, R.; Saadatmand, S.; de Roy van Zuidewijn, D.; Oosterwijk, J.; Tollenaar, R.; Ausems, M.; van 't Riet, M.; Margrethe, S.V.; Hooning, M.; Wesseling, J.; Kristine, K.; Luiten, E.; Verhoef, C.; Heijnsdijk, E.; de Koning, H.
Journal:
European journal of surgical oncology
Issue:
Volume 47:Issue 2(2021)
Page Start:
e19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search